Warfarin News and Research

RSS
Warfarin is a drug that prevents blood from clotting. It belongs to the family of drugs called anticoagulants (blood thinners).
Study finds increased heart attack risk in patients taking direct acting oral anticoagulants

Study finds increased heart attack risk in patients taking direct acting oral anticoagulants

Genotype-guided warfarin dosing linked to reduced risk of adverse events

Genotype-guided warfarin dosing linked to reduced risk of adverse events

Uninterrupted use of new anticoagulant reduces major bleeding events during atrial fibrillation ablation

Uninterrupted use of new anticoagulant reduces major bleeding events during atrial fibrillation ablation

CT scans reveal subclinical leaflet thrombosis in patients undergoing aortic valve replacement

CT scans reveal subclinical leaflet thrombosis in patients undergoing aortic valve replacement

Low-risk atrial fibrillation patients fare better without antithrombotic therapy, study finds

Low-risk atrial fibrillation patients fare better without antithrombotic therapy, study finds

Low dose of alternative anticoagulant may help prevent stroke in hemodialysis patients

Low dose of alternative anticoagulant may help prevent stroke in hemodialysis patients

Inhealthcare and Medway Community Healthcare partner to help patients manage long-term conditions at home

Inhealthcare and Medway Community Healthcare partner to help patients manage long-term conditions at home

Researchers develop performance measures to help hospitals improve warfarin management in patients

Researchers develop performance measures to help hospitals improve warfarin management in patients

Afib patients more likely to discontinue anticoagulant therapy after procedure, research finds

Afib patients more likely to discontinue anticoagulant therapy after procedure, research finds

CBD oil may reduce frequency and severity of seizures in patients with epilepsy, UAB study shows

CBD oil may reduce frequency and severity of seizures in patients with epilepsy, UAB study shows

Researchers develop portable sensor for fast, accurate assessment of blood's clotting ability

Researchers develop portable sensor for fast, accurate assessment of blood's clotting ability

Atrial fibrillation patients treated with anticoagulant drug have higher risk of developing dementia

Atrial fibrillation patients treated with anticoagulant drug have higher risk of developing dementia

New treatment strategy effective in preventing bleeding in AF patients who underwent PCI, study shows

New treatment strategy effective in preventing bleeding in AF patients who underwent PCI, study shows

Embracing digital health in the NHS: an interview with Bryn Sage

Embracing digital health in the NHS: an interview with Bryn Sage

Study provides insight into available treatments for stroke prevention in atrial fibrillation patients

Study provides insight into available treatments for stroke prevention in atrial fibrillation patients

Driving a digital revolution in the NHS: an interview with Peter Wilkinson

Driving a digital revolution in the NHS: an interview with Peter Wilkinson

New poster presented at RCGP annual conference highlights dangers of hyperpolypharmacy

New poster presented at RCGP annual conference highlights dangers of hyperpolypharmacy

Siemens announces FDA 510(k) clearance for Xprecia Stride Coagulation Analyzer

Siemens announces FDA 510(k) clearance for Xprecia Stride Coagulation Analyzer

Inhealthcare introduces first self-testing mobile app for warfarin users

Inhealthcare introduces first self-testing mobile app for warfarin users

New Focused Update to CCS atrial fibrillation guidelines released

New Focused Update to CCS atrial fibrillation guidelines released

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.